Eniola’s background in computational drug‑resistance modeling, AMR surveillance pipelines, and quantitative bio‑pharmacology aligns with Open Philanthropy’s need for data‑driven biosecurity estimates. While the focus is on biosecurity base‑rates rather than pure neuroscience, her interdisciplinary skill set and LMIC perspective make her a reasonable candidate, though the match is not exact.